Expression of DSG1 and DSC1 are prognostic markers in anal carcinoma patients

Br J Cancer. 2012 Feb 14;106(4):756-62. doi: 10.1038/bjc.2011.548.

Abstract

Background: Our purpose was to investigate if dysregulation of cell adhesion molecules could be linked to prognosis in squamous cell carcinomas (SCCs) of the anal region.

Methods: Protein expression of desmoglein-1 (DSG1), desmocollin-1 (DSC1) and E-cadherin was studied by immunohistochemistry in a cohort of 53 anal carcinoma patients treated by radiation alone or combined with 5-fluorouracil and mitomycin C.

Results: Univariate analyses identified, among others, negative membranous DSG1 staining (P=0.009), negative cytoplasmic DSC1 staining (P=0.012) and negative DSG1 (membranous)+negative DSC1 (cytoplasmic) staining (P=0.004) to be associated with improved cancer-specific survival (CSS). On multivariate analyses positive DSG1 (membranous)+DSC1 (cytoplasmic) staining (HR 6.95, P=0.044), large tumour size and lymph node metastases (HR 6.44, P=0.004) and radiation without chemotherapy (HR 6.73 P=0.004) were associated with worse CSS. On univariate analysis, improved disease-free survival was associated with negative membranous staining of DSG1 (P=0.047), and negative DSG1 (membranous)+negative DSC1 (cytoplasmic) staining (P=0.025), among others.

Conclusion: Membrane negativity for DSG1 and cytoplasmic negativity for DSC1 are favourable markers for CSS in SCCs of the anal region.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Anus Neoplasms / drug therapy
  • Anus Neoplasms / metabolism*
  • Anus Neoplasms / mortality
  • Anus Neoplasms / radiotherapy
  • Cadherins / metabolism
  • Carcinoma, Squamous Cell / drug therapy
  • Carcinoma, Squamous Cell / metabolism*
  • Carcinoma, Squamous Cell / mortality
  • Carcinoma, Squamous Cell / radiotherapy
  • Combined Modality Therapy
  • Desmocollins / metabolism*
  • Desmoglein 1 / metabolism*
  • Disease-Free Survival
  • Female
  • Fluorouracil / administration & dosage
  • Humans
  • Male
  • Middle Aged
  • Mitomycin / administration & dosage
  • Prognosis

Substances

  • Cadherins
  • DSC1 protein, human
  • Desmocollins
  • Desmoglein 1
  • Mitomycin
  • Fluorouracil